Retraction: Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: Role of STAT-3 in HCV replication (Journal of Virology (2005) 79:3 (1569–1580) DOI: 10.1128/JVI.79.3.1569-1580.2005);Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: Role of STAT-3 in HCV replication

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1569-1580

  Waris, Gulam ^a   Turkson, James ^b   Hassanein, Tarek ^c   Siddiqui, Aleem ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHELATING AGENT; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRROLIDINE DITHIOCARBAMATE; STAT3 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STRESS ACTIVATED PROTEIN KINASE; VIRUS PROTEIN; VIRUS RNA; DNA BINDING PROTEIN; JAK2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CALCIUM SIGNALING; CHRONIC HEPATITIS; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPLICON; RNA REPLICATION; TRANSACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; GENE EXPRESSION REGULATION; HEPATITIS C; LIVER; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; JANUS KINASE 2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; REPLICON; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 13744260319     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01358-20     Document Type: Erratum

References (63)

1. Abe, J., M. Takahashi, M. Ishida, J. W. Lee, and B. C. Berk. 1997. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1). J. Biol. Chem. 272:20389-20394.
2. Bartenschlager, R., and V. Lohmann. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81:1631-1648.
3. Bartenschlager, R., and V. Lohmann. 2001. Novel cell culture systems for the hepatitis C virus. Antivir. Res. 52:1-17.
4. Bowman, T., R. Garcia, J. Turkson, and R. Jove. 2000. STATs in oncogenesis. Oncogene 19:2474-2488.
5. Bowman, T., M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove. 2001. STAT-3 mediated myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 98:7319-7324.
6. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat-3 as an oncogene. Cell 98:295-303.
7. Bureau, C., J. Bernad, N. Chaouche, C. Orfila, M. Beraud, C. Gonindard, L. Alric, J. P. Vinel, and B. Pipy. 2001. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J. Biol. Chem. 276:23077-23083.
8. Calo, V., M. Migliavacca, V. Bazan, M. Macaluso, M. Buscemi, N. Gebbia, and A. Russo. 2003. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell Physiol. 197:157-168.
9. Campbell, G. G., C. L. Yu, R. Jove, and C. Carter-Su. 1997. Constitutive activation of JAK1 in Src-transformed cells. J. Biol. Chem. 272:2591-2594.
10. Carballo, M., M. Conde, R. F. Bekay, J. Martin-Nieto, M. J. Camacho, J. Monteseiris, J. Conde, F. J. Bedoya, and F. Sobrino. 1999. Oxidative stress triggers STAT-3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 274:17580-17586.
11. Catlett-Falcone, R., T. H. Landowski, M. M., Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, W. S. Dalton, and R. Jove. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105-115.
12. Chirivia, J. C., R. P. S. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
13. Choi, J., K. J. Lee, Y. Zheng, A. K. Yamaga, M. M. C. Lai, and J. H. Ou. 2004. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39:81-89.
14. Corrocher, R., M. Casaril, G. Bellisola, G. B. Gabrielli, N. Nicoli, G. C. Guidi, and G. De Sandre. 1986. Severe impairment of anti-oxidants system in human hepatoma. Cancer 58:1658-1662.
15. Costa-Pereira, A., and T. Cotter. 1999. Metabolic alterations associated with apoptosis, p. 141-156. In G. P. Studzinski (ed.), Apoptosis: a practical approach. Oxford University Press, Oxford, England.
16. de Wet, J. R., K. V. Wood, M. Deluka, D. R. Helinski, and S. Subramaniam. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:723-737.
17. Di Bisceglie, A. M. 1997. Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S-38S.
18. Dubuisson, J., F. Penin, and D. Moradpour. 2002. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 12:517-523.
19. Farinati, F., R. Cardin, N. De Maria, G. Della Libera, C. Marafin, E. Lecis, P. Burra, et al. 1995. Iron storage, lipid peroxidation and glutathione turn-over in chronic anti-HCV positive hepatitis. J. Hepatol. 22:17713-17721.
20. Finkel, T. 1998. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10: 248-253.
21. Flory, E., M. Kunz, C. Scheller, C. Jassoy, R. Stauber, U. R. Rapp, and S. Ludwig. 2000. Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral protein and involves oxidative radicals and activation of IκB kinase. J. Biol. Chem. 275:8307-8314.
22. : Gamero, A. M., H. A. Young, and R. H. Wiltrout. 2004, Inactivation of STAT-3 in tumor cells: releasing a brake on immune responses against cancer. Cancer Cell 5:111-112.
23. Garcia, R., and R. Jove. 1998. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5:79-85.
24. Gong, G., G. Waris, R. Tanveer, and A. Siddiqui. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc. Natl. Acad. Sci. USA 98: 9599-9604.
25. Guo, J.-T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferes on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
26. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
27. Kolykhalov, A. A., E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone, and C. M. Rice. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA, Science 277:570-574.
28. Li, W., X. Liang, C. Kellendonk, V. Poli, and R. Taub. 2002. STAT-3 contribute to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277:28411-28417.
29. Lohmann, V., F. Korner, J. O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
30. Lohmann, V., F. Korner, A. Dobierzewska, and R. Bartenschlager. 2001. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75:1437-1449.
31. Maria, N. D., A. Colantoni, S. Fagiuoli, G. J. Liu, B. K. Rogers, F. Farinati, D. V. Thiel, and R. A. Floyd. 1996. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radical Biol. Med. 21:291-295.
32. Muller, F. 1992. Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radical Biol. Med. 13:651-657.
33. Niu, G., R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu. 1999. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59:5059-5063.
34. Okuda, M., K. Li, M. R. Beard, L. A. Showalter, F. Scholle, S. M. Lemon, and S. A. Wienman. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366-375.
35. Pahl, H. L. 1999. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol. Rev. 70:683-701.
36. Reed, K. E., and C. M. Rice. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242:55-88.
37. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.
38. Shen, Y., K. Schlessinger, X. Zhu, E. Meffre, F. Quimby, D. E. Levy, and J. E. Darnell, Jr. 2004. Essential role of STAT-3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24:407-419.
39. Shi, S. T., K. J. Lee, H. Aizaki, S. B. Hwang, and M. M. C. Lai. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77:4160-4168.
40. Simon, A. R., V. Rai, B. L. Fanburg, and B. H. Cochran. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275: 1640-1652.
41. Sinibaldi, D., W. Wharton, J. Turkson, T. Bowman, W. J. Pledger, and R. Jove. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblast: role of activated STAT-3 signaling. Oncogene 19:5419-5427.
42. Sun, Y. 1990. Free radicals, anti-oxidant enzymes, and carcinogenesis. Free Radical Biol. Med. 8:583-599.
43. Swietek, K., and J. Juszczyk. 1997. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J. Viral Hepat. 4:139-141.
44. Tanaka, T., N. Kato, M. J. Cho, and K. Shimotohno. 1995. A novel sequence found at the 3′ terminus of the hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:744-749.
45. Tardif, K. D., K. Mori, and A. Siddiqui. 2002. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol. 76:7453-7459.
46. Tsukiyama, K. K., N. Lizuka, M. Kohara, and A. Noraoto. 1992. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66:1475-1483.
47. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545-2552.
48. Turkson, J., T. Bowman, J. Adnane, Y. Zhang, J. Y. Djeu, M. Sekharam, D. A. Frank, L. B. Holzman, J. Wu, S. Sebti, and R. Jove. 1999. Requirements for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol. Cell. Biol. 19:7519-7528.
49. Wang, C., P. Sarnow, and A. Siddiqui. 1993. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67:3338-3344.
50. Wang, T., G. Niu, M. Kortylewski, L. Burdelya, K. Shain, S. Zhang, R. Bhattacharya, D. Gabrilovich, R. Heller, D. Coppola, W. Dalton, R. Jove, D. Pardoll, and H. Yu. 2004, Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10:48-54.
51. Waris, G., and A. Siddiqui. 2002. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J. Virol. 76:2721-2729.
52. Waris, G., A. Livolsi, V. Imbert, J. F. Peyron, and A. Siddiqui. 2003. Hepatitis C virus NS5A protein and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J. Biol. Chem. 278:40778-40787.
53. Waris, G., S. Sarker, and A. Siddiqui. 2004. Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA 10:321-329.
54. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximum activation of Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
55. Xu, Z., J. T. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindrajan, D. Chien, M. Silby, and J. Ou. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840-3848.
56. Yang, C. H., W. Shi, L. Basu, A. Murti, S. N. Constantinescu, L. Blatt, E. Croze, J. E. Mullersman, and L. M. Pfeffer. 1996. Direct association of Stat-3 with the IFNAR-1 chain of the human type I interferon receptor. J. Biol. Chem. 271:8057-8061.
57. Yeh, T. C., and S. Pellegrini. 1999. The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol. Life Sci. 55:1523-1534.
58. Yu, C. L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a STAT-3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83.
59. Yu, H., and R. Jove. 2004. The STATS of cancer-new molecular targets come of age. Nat. Rev. 4:97-105.
60. Zhang, Y., J. Turkson, C. Carter-Su, T. Smithgall, A. Levitzki, A. Kraker, J. J. Krolewski, P. Medveczky, and R. Jove. 2000. Activation of STAT-3 in v-Src-transformed fibroblasts requires cooperation of JAK1 kinase activity. J. Biol. Chem. 275:24935-24944.
61. Zheng, Y. W., and T. S. Yen. 1994. Negative regulation of hepatitis B virus gene expression and replication by oxidative stress. J. Biol. Chem. 269:8857-8862.
62. Zhong, Z., W. Wen, and J. E. Darnell, Jr. 1994. Stat-3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98.
63. Zhu, H., H. Zhao, C. D. Collins, S. E. Eckenrode, Q. Run, R. A. McIndoe, J. M. Crawford, D. R. Nelson, J. X. She, and C. Liu. 2003. Gene expression associated with interferon alpha antiviral activity in an HCV replicon cell line. Hepatology 37:1180-1188.